Adis JournalsBrowse
Video.mp4 (61.94 MB)
Download file

Dabigatran Dual Therapy Versus Warfarin Triple Therapy Post-Percutaneous Coronary Intervention in Patients With Atrial Fibrillation With/Without a Proton Pump Inhibitor: A Pre-specified Analysis of the RE-DUAL PCI Trial

Download (61.94 MB)
media
posted on 2020-06-22, 08:47 authored by José C. Nicolau, Deepak L. Bhatt, Stefan H. Hohnloser, Takeshi Kimura, Gregory Y. H. Lip, Corinna Miede, Matias Nordaby, Jonas Oldgren, Philippe Gabriel Steg, Jurriën M. ten Berg, Lucas C. Godoy, Christopher P. Cannon, The RE-DUAL PCI Steering Committee and Investigators

Article full text


The above video represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020.

History

References

Usage metrics

Read the peer-reviewed publication

Dabigatran Dual Therapy Versus Warfarin Triple Therapy Post-Percutaneous Coronary Intervention in Patients With Atrial Fibrillation With/Without a Proton Pump Inhibitor: A Pre-specified Analysis of the RE-DUAL PCI Trial
DrugsDrugs

Categories

Keywords

Atrial FibrillationDabigatranCoronary Intervention

Licence

CC BY-NC 4.0

Exports